Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Otorix is a Swedish medical technology company specializing in the research and development of innovative hearing solutions, particularly in the field of bone conduction. Founded in 2004 and based in Askim, the company is the original developer of several widely used hearing systems, including the Ponto bone-anchored hearing system and the ADHEAR adhesive bone conduction device. Otorix operates as an innovation engine, advancing projects from initial research seeds to clinical application, often in collaboration with its parent company, Oticon Medical. Its technologies primarily target conductive hearing loss and single-sided deafness, benefiting hundreds of thousands of users worldwide. The company's multidisciplinary expertise allows it to drive the development of both surgical and non-surgical auditory solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Otorix.